Trial site
University of California Irvine Medical Center
- 30running trials
- 19closed trials
The trials here
What the 51 trials at this site are about, from their registry records.
- Conditions
- Lung cancer8 trials
- Bladder cancer7 trials
- High blood pressure5 trials
- Prostate cancer5 trials
- Gastric and oesophageal cancer4 trials
- Head and neck cancer4 trials
- Heart failure4 trials
- Liver and biliary tract cancer4 trials
- Ovarian cancer4 trials
- Metastatic breast cancer3 trials
- Pancreatic cancer3 trials
- Acute myeloid leukaemia2 trials
- and 24 more
- Phase
- Phase 321 trials
- Phase 28 trials
- Phase 1/27 trials
- Phase 14 trials
- Phase 42 trials
- Early phase 11 trial
- Status
- Active, not recruiting14 trials
- Completed14 trials
- Recruiting13 trials
- Withdrawn3 trials
- Enrolling by invitation2 trials
- Suspended2 trials
- Terminated2 trials
- Not yet recruiting1 trial
- Lead sponsor
- University of California, Irvine6 trials
- Janssen Research & Development, LLC5 trials
- Pfizer5 trials
- Astellas Pharma Global Development, Inc.3 trials
- Eli Lilly and Company2 trials
- and 29 more
Running trials
Recruiting
Optimizing Preeclampsia Postpartum With Point-of-care Ultrasound
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Analysis of Lung Cancer Tissue With Spatial Frequency Domain Imaging
Recruiting
Recruiting
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Active, not recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of Sasanlimab in People With Non-muscle Invasive Bladder Cancer
Active, not recruiting
Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
Active, not recruiting
Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy
Active, not recruiting
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer4 recruiting
- Gastric and oesophageal cancer2 recruiting
- Aortic aneurysm1 recruiting
- Bladder cancer1 recruiting
- Cervical cancer1 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Endometrial cancer1 recruiting
- Gestational diabetes1 recruiting
- Head and neck cancer1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Liver and biliary tract cancer1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
- Obesity1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Withdrawn
The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19
Withdrawn
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Completed
Completed
Recruiting
Completed
Terminated
Completed
Completed
A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies
Completed
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Completed
Terminated
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Completed
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026